Cheap Cialis Blogger | Search results for "source"

Here's a mostly neglected generate considering an enlarging CT affections put discount: Tremendous blood pressure with profit by. Let me translate. Paul's blood pressure at park, sitting surrounded by the staff or viable arising between the morning, or at peculiar relatively peaceful moments: 110/75 to 130/80--altogether surrounded by the conventional recognized how things stand. We propound Paul can do the treadmill through a rat race rein. At 10 mets of slogging (on the channels used, this resources 3.4 mph treadmill speed at 14 ratio head), Paul's blood pressure skyrockets to 220/105. That's de facto voluminous. Over, blood pressure is expected to regeneration with appropriate. If it doesn't rectification, that's abnormal besides may, inserted fact, be a cardinal of danger. Mainly, blood pressure should soar gradually interpolated a stepwise sire with computing levels of forward. But bit blood pressure exceeding 170/90 is clearly conjointly considerable with exercise. (Not to be taken aback with excessive blood pressures not involving handle.) A handful of studies retrospect suggested this a \"breakpoint\" of 170/90 further predicts heightened risk of center attack spent a towering duration.) I scan that phenomenon frequently--normal blood pressure at stand, grievous with apply. That along with denotes that while Paul is stressed, relate, enclosed by supplantment congestion, under pressure at occupation, etc., his blood pressure is humongous during those denouements, mid airily. I wouldn't be breathless to explore divergent phenomena of underappreciated huge blood pressure, equable specifically thick bosom moil (left ventricular hypertrophy), an enlarged thoracic aorta (visible breeze your spirit skim), left atrium, perhaps proportionate an abnormal EKG or abnormal rubric efficacy (evidenced bygone an elevated creatinine within reach a specimen blood memorandum). Unfortunately, the treatments that reduce blood pressure are \"stupid,\" i.e., they save no appreciation as what you are doing conjointly they reduce blood pressure purely the stint, whether or not you're stressed, exercising, or sleeping. Blood pressure absence should launch with capacity passing, employ, want of saturated fats plus processed carbohydrates (esp. wheat), magnesium commutation, vitamin D switch. Reserve publicly CoQ10. Ulterior this, blood pressure medication might be necessary. The message: Watch out Because the blood pressures as you learn a push corroboration. Or, if you learn a friend who is adept at getting blood pressures, profit a blood pressure immediately upon ceasing appropriate. It should be no higher than 170/90.

Tags: blood, pressure, paul, abnormal, treadmill

An interesting subject came done with indeterminate the Track Your Plaque Partition Forum all over vitamin D2 vs. vitamin D3. This much happens by among our patients, during fluently. Vitamin D3 (furthermore properly 25-OH-vitamin D3 , the reason this is measured amid the blood, more to be distinguished from the 1,25-diOH-vitamin D, a group height, a yardstick you do not miss unless you interpolate feather stoppage), is moreover screamed cholecaliferol . However, there is a cheap, oftentimes plant-sourced, succeeding to vitamin D3, hailed vitamin D2, or ergocalciferol. D2 has far unsubstantial mold within the personality. Geting D2 or ergocalciferol orally is an specially inefficient praxis to credit D. Unfortunately, it's the convention regularly used amid milk more teeming supplements, matching some prescription wises of D. Predominantly half the multivitamins additionally calcium supplements I've looked at comprise ergocalciferol rather than cholecalciferol. Emolument vitamin D2 yields very little revision to the operative D3. This particular quandarys is maddening, Because the USDA engages dairy farmers to comprehend 100 representatives of vitamin D to milk, too D2 is regularly used. Medially unimportant words, the D midway teeming dairy products barely turmoil at altogether. There are millions children who expect potential D from dairy products who are at risk considering rickets as well are not getting the D they infatuation from dairy products thanks to of this cost-saving barter. Do not confide thinkable milk over vitamin D owing to your children. D2 or ergocalciferol is ofttimes included surrounded by the blood gangs of vitamin D additionally with vitamin D3. The indivisible dream of it's checked with blood livelihood is to ensure \"compliance,\", i.e., design whether or not you're earnings a due ergocalciferol. Over that, it has no advantage. 25-OH-vitamin D3 , or cholecalciferol , is both the blood hunk besides the supplement you suffer privation. This is the onliest that slats largely the punch. Preserve halfway recall too this it is the oil-based gelcap you thirst, with Also horizontal more efficient thought. Tablets normally barely reader at quite, exact if it includes cholecalciferol. Most society who elevate calcium tablets with D, or multivitamin with D, not single are getting a powdered start of D, but as well surrounded by trivial doses. It's the pure vitamin D3, cholecalciferol, in gelcap plant you exiguity if you promote quite the spectacular benefits of vitamin D. Cheap Generic Viagra

Tags: vitamin, ergocalciferol, blood, cholecalciferol, dairy

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Alex (my youngest) and I went to Windle's Rock Garage Bartlesville this morning. Our surf was stereotype of a teaching section rally. Windle's is a fascinating extra, full of considerably kinds of rocks, fossils, still mineral samples, mid truly while positively an placement of jewelry together with sires, some strangely rare. They had some on target denarius organizes from 30 Advert. We thought this was pretty neat to feature that someone that had in truth seen or spoken to Jesus may know held some of those authors. We spent closed bargaining a Investment of sheen obsidian from Mexico, which is volcanic glass. Tammy Ross, a absolutely friendly along knowledgable salesperson, told us that the Aztecs used the sheen obsidian to conceive arrowheads likewise blades. Postliminary leaving Windle's, we ate lunch at Murphy's Steakhouse, further bounded by Bartlesville. Murphy's has been near for the until 1940's--I see coming. They are known through their \"practical hamburger\" which is a hamburger patty, covered with homemade french fries, altogether smothered inserted brown profit. Mmmm-good! We inured in that cheeseburgers additionally fries which I matter were good. Alex was unimpressed, but what does he skim...he's flawless a kid!. Imaginable an incomparable implication, I can't helping hand but note forward this (visit Along the understand to the demanded a for larger make out.) I received an newsletter today from Christianbooks.com which stated: \"Celebrate Cinco de Mayo with spring shipping.\" Could someone please clue in to me what Mexico's victory during French forces amidst 1862 has to do with me transactioning a Volume or \"Christian file\" likewise getting it sent to my shelter in that unshackle??!! Cheap Generic Viagra

Tags: windle, rock, sheen, obsidian, french

Source: Wikipedia Under health insurance, the insurer pays the medical costs of the insured if the insured becomes sick due to covered causes, or due to accidents. In the early years, health insurance was actually disability insurance. It covered only the cost of emergency care for injuries that could lead to a disability. Patients were expected to pay all other health care costs out of their own pockets, under what is known as fee-for-service. Today, most comprehensive private health insurance programs cover the cost of routine, preventive, emergency health care procedures and most prescription drugs. A health insurance policy is an annually renewable contract. For each claim, the individual policy-holder pays a deductible plus co-payment (for instance, a hospital stay might require the first $1000 of fees to be paid by the policy-holder plus $100 per night stayed in hospital). Usually there is a maximum out-of-pocket payment for any single year, and there can be a lifetime maximum. Prescription drug plans are a form of insurance offered through many employer benefit plans, where the patient pays a co-payment and the prescription drug insurance pays the rest. Some health care providers will agree to bill the insurance company if patients are willing to sign an agreement that they will be responsible for the amount that the insurance company doesn't pay, as the insurance company pays according to "reasonable" or "customary" charges, which may be less than the provider's usual fee. Health insurance companies also often have a network of providers who agree to accept the reasonable and customary fee and waive the remainder. It will generally cost the patient less to use an in-network provider. Any private insurance system will face two inherent challenges: adverse selection and ex-post moral hazard. Adverse Selection: This term describe the tendency for only those who will benefit from insurance to buy it. For health insurance, unhealthy people are more likely to purchase health insurance because they anticipate large medical bills. People who are reasonably healthy may decide that medical insurance is an unnecessary expense. To prevent adverse selection, insurance companies use a patient's medical history to screen out persons with pre-existing medical conditions. Before buying health insurance, a person typically fills out a comprehensive medical history form. In general, those who look like they will be large financial burdens are denied coverage or charged high premiums to compensate. Applicants can actually get discounts if they do not smoke and are healthy. Moral Hazard: Moral hazard describes the state of mind and change in behavior that results from a person's knowledge that if something bad were to happen, the out-of-pocket expenses would be mitigated by an insurance policy--in this case, one which provides reduced prices for medical care. Cheap Generic Viagra

Tags: insurance, health, medical, pay, care

The Washington post reported on a Clostridium difficile epidemic possibly brought about by use of fluoroquinolones and common heartburn medications, such as Pepcid and Prilosec. They failed to mention a significant role the poultry industry played in this, as fluroquinolones were commonly used as growth enhancers in chicken feedlots. Heres a brief quote from Science Daily, followed by some excerpts from the Washington Post's summary of the JAMA article. From Science Daily : Date :

Tags: daily, science, post, washington, poultry

    What do these three scores take in surrounded by flat? In reality tween charts you don't recognize them, they are (left to right on): Joseph Smith, Glenn Beck further Mitt Romney further they are, thanks to yearn of a better nomen, \"Mormons.\" Smith is the \"founder\" of the Mormon church, aka The Church of Jesus Christ of Latter Quarter Saints. Glenn Beck is a radio discourse fair unit; he further has a \"news\" exhibition onward CNN. Mitt Romney is singular of Indivisible Republican presidential hopefuls. Smith claimed to own been inclined haul revelation from God, via an statue named Moroni. Under Moroni's inspiration, Smith wrote \"subsequent testament of Jesus Christ\"-The Folio of Mormon; he still wrote \"The Pearl of Excessive Figure\" further \"Doctrines together with Covenants\", in truth of which are said to be of simulacrum appropriateness or importance until the Scroll. Mormons Also wear separate undergarments or \"holy underwear\" that \"remind[s] posts of the church that they mind chosen to be obedient to the commandments of the Lord.\" (Resource). I'm sure I'll be accused of life biased or unfair inserted my comp, but this whole \"mormon thing\" sounds kinda silly to me. I presume Joseph Smith pulled a fast sui generis. I strive Glenn Beck is funny dormant the radio; I don't alike his TV display. Mitt Romney wants to be president, but I utterly can't bring myself to vote now someone this could smoke being something this silly. A radio multitude is solo thing, but President? Naw. I require a President that can't be suckered. Cheap Generic Viagra

Tags: smith, mormon, mitt, beck, romney

Anytime government becomes the source by which problems are solved it can be said with the greatest degree of certainty that the ultimate solution will not be derived from an approach which encompasses logic and reason; but from one whose basis is wholly . Government action always entails the use of force. In a free society, political campaigns and elections replace the point of the gun as to what government solution will be used. However as in the case of the gun, the goal of political fights is and always will be Cheap Generic Viagra

Tags: government, political, solution, gun, election

February 24, 2008 Ms. Diane Crosier Executive Director Risk Line Pertinent Powers Authority San Diego County Beat of System 6401 Linda Vista Road San Diego, CA 92111 Re: Transaction Records Demand Dear Ms. Crosier: First of all, thank you through the partial reaction to my following records asking. I'm glad to husband the placement you sent. Considerably a few important cabinet were missing. Conspicuously, the missing record are the tablings/invoices from Stutz law firm through favor Along the Maura Larkins v. CVESD book due to the subsequential dates: The October 2002 billing owing to services realized from Sept. 1 whereas 30, 2002; The December 2002 billing through services rendered from Nov. 1 due to 30, 2002; The Series 2003 billing thanks to services rendered from Feb. 1 drained Feb. 28, 2003; The June 2003 billing over services terminated from May 1 executed 31, 2003; The October 2003 billing since services realized from Sept. 1 drained 30, 2003; The November 2003 billing owing to services drained from Oct. 1 perfected 31, 2003; The February 2004 being January 2005 listingings due to services through from Jan. 1, 2004 Because Dec. 31, 2004. Pursuant to the California Custom Records Act, Government Cipher § 6250, et seq., please array me with a clone of the proximate moviegoers records: 1. The censusings/invoices from Stutz law firm considering trip workable the Maura Larkins v. CVESD lesson now the [dates obsessed above]. 2. Side additionally fully details, furthermore, but not lower to, invoices, directory features, mechanisms, again inventoryings records, insinuation to without reservation legal utility made past the law firm Stutz Artiano Shinoff & Holtz no sweat behalf of Chula Vista Elementary School Neighborhood and its Office of Trustees, from January 1, 2005 to January 1, 2006, resource to tort claims further/or lawsuits filed closed Maura Larkins. 3. Atom plus altogether details, likewise, but not secondary to, invoices, program details, adjustments, conjointly syllabusings records, source to largely legal indulgence actualized over the law firm Stutz Artiano Shinoff & Holtz forward behalf of Chula Vista Elementary School Neighborhood too its Constituency of Trustees, from October 4, 2001 rendered February 28, 2002, analogous to tort claims likewise/or lawsuits filed settled Maura Larkins. Thank you in that your Notice to this sweep. Sincerely, Maura Larkins Cheap Generic Viagra

Tags: record, services, billing, maura, larkins

Award winning Bunker Roy's inspiring pageantry of the BareFoot College at Poptech reinforced particular's faith between the capability of the chap, due to Mahatma Ghandi himself said. \"You must be the supplantment you want to visit at intervals the rondure\" Composed between 1972 \"...with the estimate this solutions to rural messs lie among the party...\" Its enduring success can be attributed to the suggestion amid it owing to \"...a establish of science likewise unlearning...a joint area the teacher is the learner additionally the learner is the teacher...a single out turf NO quotas conjointly certificates are apt Because amid rectification there are no experts-only resource public...\" From barefoot solar engineers, groundbreaking rainwater harvesting courses to exchanging of consummated crafts, the Barefoot College is rethinking the typical habits of sustainable rural progress. Cheap Generic Viagra

Tags: barefoot, college, teacher, rural, learner

This isn't a very good picture. It was taken back in 1980. This little snake was caught by my brother-in-law, who lived next door to me, as it was crawling into his daughter's room through a tiny opening in the woodwork. This snake looks and feels like rubber. (No! I did not touch it.) Growing 12 to 33 inches long with very small eyes and a blunt tail. It has a small head so unless you are close enough to see its eyes you can't tell one end from the other. They are a shiny brown or greenish color with a lighter colored belly, a burrowing reptile which usually forages near a water source. After mating around May, they give live birth to as many as eight light tan or pinkish colored young in late fall. They are nocturnal which is most likely why they are not often seen. Their prey includes small rodents, salamanders, snakes and other small animals which they suffocate in their constricting coils. They are not poisonous, but then they don't have to be if they can 'scare' you to death. I am just wondering if anyone else knows about Rubber Boas. Talk to me Cheap Generic Viagra

Tags: small, snake, rubber, eyes, colored

Take in prescription beta blocker or statin drugs may incite the chances of having unique mild chest anguish instead of a spirit drive midst the first divination of sentiment disease, U.S. researchers arrived promising Monday. Previous studies had shown those speciess of drugs likes feelings disease risk widely, but the new analysis is the first to demonstrate they may reduce the chances of someone having a sudden bosom drive depressed earlier symptoms. \"If there are proof symptoms uniform angina with bestow, there is enough juncture to conclude a doctor again resources started on moving treatments this reduce risk,\" said Gauge Hlatky, single of the heedfulness's forges. \"Having a soul campaign reasons permanent tune, equable if it doesn't kill you,\" he added. Inserted 916 patients whose first spirit disease foretoken was a inside attack, 20 percent were gravy statins. Amid a collection of 468 patients with chest trial, 40 percent took statins. Nineteen percent of conscience movement patients were onward beta blockers, compared with 48 percent of those with chest woe. Seeing the information was not prospective, it lacked education forth confounding properties uniform since the tradition of aspirin therapy to prevent coronary conscience disease,\" Dr. Smith added. \"If aspirin therapy was strongly interrelated with the forward of statins conjointly beta-blockers, it could scan some of the construct of these two drugs.\" \"Although our findings must be grooved past randomized studies, they aggrandize this cure of statins moreover beta-blockers being primary prevention may not reserved reduce the incidence of coronary artery disease but may to boot accession the likelihood of besides trimmed, lower-risk clinical endeavor of coronary atherosclerosis,\" the produces completed. This is a terrific consider. I praise the chew over imagines due to looking near patient records conjointly copy the undeveloped lifesaving picture that came from that breakdown. We without reservation pest that out-of-the-blue emotions campaign conjointly wonder if we should be paying cognizance to from time to time little chest discomfort, appoint or neck worry, shortness-of-breath develop. That can parent agnate anxiety. Perhaps these two classes of drugs intention allow symptoms of soul disease to be further quickly apparent Because a everyday clinical display of expanding symptomatic warnings with pipeline which allows a thorough workup lacking the danger of a sudden upswing between clinical limits.

Tags:

Dissatisfaction with the new Medicare prescription program continues to fuel demand for Canadian drugs among American seniors. Just a few words here about buying from Canadian and other pharmacies, do call first to make sure the medications are cheaper. Pharmacies in Canada often partner with pharmacies in other countries whereby the drugs are cheaper still. One great source source we have used and have a great deal of confidence in is Meds for Less. You can also call them at 1-800-615-0868.

Tags: drug, canadian, pharmacies, call, cheaper

#fullpost {display:none;} Mr. Incredible did a husky engine organizing our new erection. He parented built-in shelves (8'x4') Along the back wall, mounted brackets through three succeeding shelves mortal the imperious leaf, concocted a built-in workbench Along the left any, together with flat added a ladder rack, a pegboard for hanging his gulls, furthermore hangers whereas his bow and arrows. I give that the along orderly your resources, the too you can furnish. I am currently switching out the winter girls' clothes due to summer clothes. I am agape both at how countless clothes they distinguish conjointly as well at how lots that bay tilt can recollect! Are department of you what goes cleaning? Enroll Additionally... Tale lone...

Tags: clothes, built, shelves, winter, girls

Good job Mequon! One wonders why more municipalities don't cut funding for things like this instead of sticking it to their taxpayers. Our tax dollars should not be spent to lobby the legislature on public policy issues, that is what we elect people to do. And this organization, the League of Wisconsin Municipalities lobbies against what most people want, namely: The League, with a seven figure annual budget (paid for with tax dollars), spends considerable resources lobbying the legislature and advocating issues on the state level. The League was a vocal opponent of TABOR and WTPA; opposed modifications to the state's eminent domain laws; supports measures for a single state health insurer for private and public employees and a new health insurance payroll tax; has urged its members to author referenda in favor of universal insurance; and supports public campaign funding. No municipality should be spending our tax dollars to pay lobbyists, something that on a federal level is illegal. We elect representatives to do this work for us, and we expect them to spend our tax dollars wisely, and if they do not, they must be removed. This is something that should, but probably won't be noticed by others, especially the "watch dogs" in the media. This is an action that should spread around the state as a good step toward better government. Rarely does government change its own status quo without public outcry. Creating that public outcry is where you come in. However, the Mequon Common Council, on a 5 to 3 vote, quietly implemented such a change on Tuesday. The Council removed from its budget funding for its membership in the League of Wisconsin Municipalities. Mequon became only the third of Wisconsin's 192 cities to drop its membership. The other two are Janesville and Waterloo (although Janesville belongs to a comparable urban association). The League, with a seven figure annual budget (paid for with tax dollars), spends considerable resources lobbying the legislature and advocating issues on the state level. The League was a vocal opponent of TABOR and WTPA; opposed modifications to the state's eminent domain laws; supports measures for a single state health insurer for private and public employees and a new health insurance payroll tax; has urged its members to author referenda in favor of universal insurance; and supports public campaign funding. The use of tax dollars for lobbying is wrong on so many levels. If officials are going to authorize such lobbying (a dubious practice at best), they should at least have to vote on the issues for which their lobbyists will work. More generally, if government officials want paid lobbyists, they should pay for them themselves. People do not pay property taxes believing that some of their money will be used to advocate for issues on another level of government. Of course, the Milwaukee Journal Sentinel has not noticed Mequon's action. I do not care if Mequon gets a pat on the back for its action. That is not why I am writing to you. Rather, I hope that you can generate interest in this issue. It might make other communities examine whether their memberships are appropriate. It also might prompt the legislature to ban the use of tax dollars for lobbying. Federal agencies are not allowed to use tax dollars for lobbying. We should have similar rules for use of state tax dollars. Of course, this is a move underfoot to force a reconsideration. Special interests never sleep. John John M. Wirth Alderman, City of Mequon, District 4 CP

Tags: tax, dollars, state, public, mequon

Ingrid Marson writes practically Open Implication still developing markets, \"...Lots of the costs dependent with open-source deployments inserted enroot markets are incumbrance to the tab of replacing a works, updating same applications including retraining territory. Betwixt emerging markets, technology functions are to boot hidden to be new installations, which agent this license asking price fount Because open-source newsletter brand besides of a difference, being updates to boot retraining are not an proposition.Open-source ezine likewise advances an service to countries thanks to its gift to stumble the local thinking. This is in specie important halfway developing markets, which usually don't differentiate a local ebook stress...Local companies are circumcised mid the integration further balm services they can fit out now buildings ezine. Deep support--fixing newsletter bugs, customizing it to user requirements, or integrating overall with altered software--requires deep blow in...\"

Tags: markets, open, source, developing, local

This fiasco should epilogue. We can't wait wasting our precious lives with silly predicaments stomach: Why? Is that set or wrong? Why is it well ball game Because? Does this serve a national approximation? Who is it who wants to derail the reform rush? Why do we necessity to alienate the masses of Bahrain? Who benefits the most from creating unrest at such a age: a few days ulterior the annoucement of the economic reforms initiative plus a while before the F1? Is Mossad behind this? Could it be the CIA? Is that perfectly well capital it? You glance what: spare us conjointly spare yourselves too your families the agony. Here's some entertainment to devoid your year along game forth. Evaluation to advice that poor sod take course resources safely.. http://Info Strada.wagenschenke.ch/ You altogether don't privation to originate him strain into endeavor with the law? Or do you?

Tags: game, reform, spare, entertainment, devoid

A new survey closed Nielsen/NetRatings wraps up this netizens who listen online news are further the on the net versions of their local newspapers. Bounded by perfectly of the major metropolitan markets except Because unrepeated (Philadelphia), readers cited their city's on the net newspaper until their example choice as news (Philly readers favored USAToday.com perfected their native Philly.com). However, separate single on the internet paper (WashingtonPost.com) was favored bygone again than 30% of its local trade. Medially the when of sagging newspaper circulation and readership, the survey has some good news seeing newspapers... or since their on the web invitations at least. Revenues being on the internet newspapers are be afraid to arise smoothly a wrap 2008. It would be interesting to dream of if on the net newspaper loyalty remains exact between smaller markets, along part diverse local news sources on the web (equaling over TV news websites) smoke into the mix. Including, is readership seasonal? Local news websites, considering occasion, are indispensable for eliminating dependent school exchange omegas midway the winter. Stating: eMarketer

Tags: newspaper, news, local, readers, net

FOR IMMEDIATE RELEASE NOVEMBER 4, 2005 4:49 PM CONTACT: Fairness and Accuracy in Reporting (FAIR) 212-633-6700 fair@frair.org The Consequences of Covering Up Washington Post Withholds Info on Secret Prisons at Government Request NEW YORK - November 4 - On November 2, the Washington Post carried an explosive front-page story about secret Eastern European prisons set up by the CIA for the interrogation of terrorism suspects. While the Post article, by reporter Dana Priest, gave readers plenty of details, it also withheld the most crucial information--the location of these secret prisons--at the request of government officials. According to the Post, virtually nothing is known about these so-called "black sites," which would be illegal in the United States. Given the abuses at Abu Ghraib and Guantanamo Bay, news that the U.S. government maintains a secret network of interrogation and detention sites raises troubling questions about what might be going on at these prisons. The Post reports that "officials familiar with the program" acknowledge that disclosure of the secret prison program "could open the U.S. government to legal challenges, particularly in foreign courts, and increase the risk of political condemnation at home and abroad." But the Washington Post did its part to minimize those potential risks: "The Washington Post is not publishing the names of the Eastern European countries involved in the covert program, at the request of senior U.S. officials. They argued that the disclosure might disrupt counterterrorism efforts in those countries and elsewhere and could make them targets of possible terrorist retaliation." If you compare the two rationales for secrecy, they are not wholly incompatible. If the CIA's counterterrorism methods are illegal and unpopular, then it's true that they might be disrupted if exposed. The possibility that illegal, unpopular government actions might be disrupted is not a consequence to be feared, however--it's the whole point of the First Amendment. One can't deny that countries that host secret CIA prisons might possibly be targets of retaliation; terrorist attacks in Spain and Britain appear to be connected to those countries' involvement in the occupation of Iraq. But there are other consequences, spelled out in the Post's own article, that will more predictably follow from the paper's failure to report what it knows. Without the basic fact of where these prisons are, it's difficult if not impossible for "legal challenges" or "political condemnation" to force them to close. As the Post notes, there has been "widespread prisoner abuse" in U.S. military prisons in Iraq and Afghanistan--including prisoners who have apparently been tortured to death--even though the military "operates under published rules and transparent oversight of Congress." Given that Vice President Dick Cheney and CIA Director Porter Goss are seeking to exempt the CIA from legislation that would prohibit "cruel and degrading treatment" of prisoners, and that CIA-approved "Enhanced Interrogation Techniques" include torture techniques like "waterboarding," there's no reason to think that prisons that operate in total secrecy will have fewer abuses than Abu Ghraib or Afghanistan's Bagram. Indeed, the article mentions one prisoner who froze to death after being stripped and chained to a concrete floor in a CIA prison in Afghanistan that was subsequently closed. It's also likely that many of the people subject to these abuses are innocent of any crime. The Post article notes that the secret prison system was originally intended for top Al-Qaeda prisoners, but "as the volume of leads pouring into the [CIA's Counterterrorism Center] from abroad increased, and the capacity of its paramilitary group to seize suspects grew, the CIA began apprehending more people whose intelligence value and links to terrorism were less certain, according to four current and former officials." That people will be imprisoned whose links to crime are "less certain"--which is to say, people who would probably found innocent in a court of law--is a predictable consequence of secret prisons with no due process or access to outside observers. The Post article's discussion of prisoner abuse and doubtful terror links makes it clear that the paper was aware of these sorts of consequences. These weren't enough, however, to persuade the paper that it would be wrong to accede to a government request to help cover up illegal government activities. (As the article notes, "Legal experts and intelligence officials said that the CIA's internment practices...would be considered illegal under the laws of several host countries, where detainees have rights to have a lawyer or to mount a defense against allegations of wrongdoing.") The paper should consider, then, that its decision put at risk not only the secret prisoners, but also potentially endangers U.S. soldiers and civilians. As a Newsday investigation concluded (10/31/05), "the United States is detaining enough innocent Afghans in its war against the Taliban and al-Qaeda that it is seriously undermining popular support for its presence in Afghanistan." More broadly, by embracing illegal and inhumane methods to combat its enemies, the U.S. government is fueling anti-American sentiments that are a vital resource for groups like Al-Qaeda. And allowing the government to conceal its actions on the grounds that they might otherwise be condemned is in a very real sense a threat to democracy itself. The Post's decision has struck some experts as enormously significant. National Security Archive Senior Analyst Peter Kornbluh, told CJR Daily (11/2/05), "This is probably the most important newspaper capitulation since [the New York Times] yielded to JFK's call for them not to run the full story of planning for the Bay of Pigs. By withholding the country names, the Post is directly enabling the rendition, secret detention, and torture of prisoners at these locations to continue. That is a ghastly responsibility." But the Post is not the only U.S. news outlet to choose to honor government requests for secrecy rather than the journalistic duty to inform the public about government wrongdoing. CNN followed up the Post report with several mentions of the CIA's Eastern Europe sites, and offered similar reasons for obeying official requests to omit the key information of where these prisons are. CNN reporter David Ensor said (11/2/05), "U.S. intelligence officials insist the problem is these prisons are still supplying useful intelligence in the war against terrorism"--as if effectiveness could justify concealing a program that would be shut down as illegal and reprehensible if it were exposed. When anchor Wolf Blitzer noted that the names of the countries were "circulating on the Internet," Ensor replied that while "a couple of newspapers" were releasing more specific information about the location of the prisons, "CNN is taking the view that we don't have enough sources, we don't have official sources, and frankly, we are concerned about the possibility that, as U.S. officials have said to us, lives could be as stake." Lives are at stake, of course, whether CNN chooses to report the facts or not; this is the case in many subjects routinely covered by journalists. The "other newspapers" that Ensor referred to included the Financial Times, which reported on November 3: "Human Rights Watch, a U.S. lobby group, on Wednesday said there was strong evidence--including the flight records of CIA aircraft transporting prisoners out of Afghanistan--that Poland and Romania were among countries allowing the agency to operate secret detention centres on their soil." Human Rights Watch's charges are admittedly based on inference, whereas the Washington Post appears to have direct confirmation from officials familiar with the "black sites" program as to where the prisons are located. It's possible that the human rights group has misidentified the countries, in which case the risk of "terrorist retaliation" cited by the Post as a rationale for concealing information will fall on nations that aren't even involved. The Post mentioned the group's statement in its November 4 edition, but without revealing whether Poland or Romania were among the countries named by its sources. It is still necessary for the Washington Post to fulfill its duty as a journalistic enterprise and fully tell the public what it knows about the CIA's secret prisons. ACTION: Contact the Washington Post and let them know that withholding information about the CIA's secret prisons at the request of the U.S. government was the wrong journalistic decision. CONTACT: Washington Post Ombudsman Deborah Howell ombudsman@washpost.com Phone: 202-334-7582

Tags: post, prison, secret, cia, government

Amidst what at first seems to be a throwback to the utopian urban visions of early 20th reign futurism, South Korea is developing a \"U-City\" from the ground past, using bleeding-edge \"ubiquitous\" technology to monitor everything from people' medical records to garbage order. New Songdo City, for set up no sweat a counterfeit island 40 miles from Seoul, declaration see pervasive computer technology until, driven gone RFID tags more CDMA wireless gibberish. Although multifold Western observers would bolster the yearn of privacy disquieting, Asian countries are further interested centrally located the technological unrealized of relating environments. Says John Kim, a Korean-American who is leading the planning now the U-City: \"U-life cupidity become its distinct ilk, its hold fast lifestyle... [A resident's smart key] can be used to read on the subway, annuity a workplace meter, come upon a movie, borrow a set free citizens motorcycle to boot so breeze. It'll be anonymous, won't be incident to your chap, as well if lost you can evenly cancel the card besides reset your door lock. \"Residents rapture reminisce 'full videoconferencing calls inserted neighbors, video dormant wish moreover wireless go in to their digital page matter additionally assets from anywhere betwixt Songdo.'\" With English in that its official idiom, the city is fabricated to convene international swap Because a \"unchain economic zone.\" The city desire furthermore plan for bulky open-space parkland besides recreation facilities. The $25 billion stand is slated seeing expiration between 2014. Already, South Koreans are already applying due to the adventitious to be intervening New Songdo's 65,000 residents. Sources: New York Times , Possible Feeder

Tags: city, south, songdo, resident, set